GOALS

The Medical Advisory Board serves as a key entity within Pharmact Holding AG and its affiliated companies.

With its interprofessional medical expertise, this consultative body significantly contributes to making strategic decisions that are scientifically grounded, regulatory compliant, and market-focused.

A highly skilled medical panel is essential to guarantee that innovations meet contemporary medical standards, clinical trial procedures are enhanced, and new products gain market approval more swiftly.

Through the ongoing expansion of its network, Pharmact Holding AG reinforces its role as a pioneering and scientifically-backed player in the healthcare industry.

SPONSOR

Pharmact Pharmaceuticals GmbH particularly benefits from this expertise by utilising the scientific counsel of the Board to reinforce its standing within the competitive environment and to continue building research partnerships with esteemed academic establishments.

This scientific knowledge supports the potential to refine market positioning and foster groundbreaking collaborations with leading medical institutions and universities.

EXTRACT – MEMBERS

Prof. Dr. med. Stefanie Kürten
Anatomical Institute of the University of Bonn, Germany

Dr. med Logan James Yilmaz
Cardiologist,Clinical Research & Trials University of Zürich, Schweiz

Prof. Dr. med. Andreas Kurth
Director Center for Orthopaedic and Trauma Surgery, Frankfurt, Germany
Clinical Research Bone Tumor, Osteology
Vorsitzender Dachverband Osteologie e. V.

Prof. Dr. med. Robert Pflugmacher
Head Physician Clinic for Orthopedics, Mechernich, Germany

Prof. Dr. med. Abderahman Machraoui
Cardiologist, Clinical Trials; Bochum, Germany / Maroc

Dr. med. Florian Beyer
Rheumatology  Osteology (DGO)  Orthopedics, Kaiserslautern, Germany

PD Dr. med. Bronek M. Boszcyk
Visiting Professor Nottingham Trent University